Experience

Vascular Perfusion Solutions, Inc.

• United States
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Scientific Director

  • Oct 2020 - Present

  Novel Oxygenated Hypothermic Machine Perfusion Technology: no one should die waiting for an organ transplant. Novel Oxygenated Hypothermic Machine Perfusion Technology: no one should die waiting for an organ transplant.



UT Health San Antonio

• United States
• Higher Education
• 700 & Above Employee

• Scientific Researcher

  • Aug 2016 - Oct 2020

  • Worked in Cancer Chemoprevention Laboratory on investigating effects of natural anti-cancer chemotherapeutic agents derived from medicinal plant extracts. • Examined molecular mechanisms of antagonizing effects of natural glucocorticoid cortisol and synthetic glucocorticoid dexamethasone on improving the outcome of chemotherapy in breast and colon cancer. • Collaborated with scientists from Embry Riddle Aeronautical University on designing and facilitating scientific payloads aboard… Show more • Worked in Cancer Chemoprevention Laboratory on investigating effects of natural anti-cancer chemotherapeutic agents derived from medicinal plant extracts. • Examined molecular mechanisms of antagonizing effects of natural glucocorticoid cortisol and synthetic glucocorticoid dexamethasone on improving the outcome of chemotherapy in breast and colon cancer. • Collaborated with scientists from Embry Riddle Aeronautical University on designing and facilitating scientific payloads aboard suborbital rockets. • Performed scientific studies using different in-vitro (cancer, T cells) and in-vivo (zebrafish, mice) models exposed to various gravity environments as a precursor to suborbital flights. • Examined the role of tissue hypoxia and inflammation using novel ex-vivo models of organ preservation. • Authored/co-authored scientific publications; presented at meetings and conferences; participated in acquiring research funding including writing grant proposals. Show less • Worked in Cancer Chemoprevention Laboratory on investigating effects of natural anti-cancer chemotherapeutic agents derived from medicinal plant extracts. • Examined molecular mechanisms of antagonizing effects of natural glucocorticoid cortisol and synthetic glucocorticoid dexamethasone on improving the outcome of chemotherapy in breast and colon cancer. • Collaborated with scientists from Embry Riddle Aeronautical University on designing and facilitating scientific payloads aboard… Show more • Worked in Cancer Chemoprevention Laboratory on investigating effects of natural anti-cancer chemotherapeutic agents derived from medicinal plant extracts. • Examined molecular mechanisms of antagonizing effects of natural glucocorticoid cortisol and synthetic glucocorticoid dexamethasone on improving the outcome of chemotherapy in breast and colon cancer. • Collaborated with scientists from Embry Riddle Aeronautical University on designing and facilitating scientific payloads aboard suborbital rockets. • Performed scientific studies using different in-vitro (cancer, T cells) and in-vivo (zebrafish, mice) models exposed to various gravity environments as a precursor to suborbital flights. • Examined the role of tissue hypoxia and inflammation using novel ex-vivo models of organ preservation. • Authored/co-authored scientific publications; presented at meetings and conferences; participated in acquiring research funding including writing grant proposals. Show less



Medical University of South Carolina

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Senior Research Specialist

  • 2011 - 2016

  • Developed, designed, and executed complex research projects, reviewed progress, analyzed data, and evaluated results. • Formulated research methods and suggested options for improving quality; identified potential problems, recommended and implemented solutions. • Generated human TIL (tumor-infiltrating lymphocytes) from primary and metastatic tumors aimed at developing a cellular product for immune-based therapies for cancer patients. • Led pre-clinical studies with lung cancer… Show more • Developed, designed, and executed complex research projects, reviewed progress, analyzed data, and evaluated results. • Formulated research methods and suggested options for improving quality; identified potential problems, recommended and implemented solutions. • Generated human TIL (tumor-infiltrating lymphocytes) from primary and metastatic tumors aimed at developing a cellular product for immune-based therapies for cancer patients. • Led pre-clinical studies with lung cancer animal models on combinational immune therapies as a precursor to human clinical trials. • Performed experiments in A Phase IB/II study of nivolumab in combination with ALT803 in lung cancer patients. ClinicalTrials.gov Identifier: NCT02523469. • Conducted pre-clinical studies on genetically engineering T cells. • Organized, maintained the laboratory and lab ordering, training of personnel, researching and recommending equipment, and maintaining documentation and storage of biomaterials. Show less • Developed, designed, and executed complex research projects, reviewed progress, analyzed data, and evaluated results. • Formulated research methods and suggested options for improving quality; identified potential problems, recommended and implemented solutions. • Generated human TIL (tumor-infiltrating lymphocytes) from primary and metastatic tumors aimed at developing a cellular product for immune-based therapies for cancer patients. • Led pre-clinical studies with lung cancer… Show more • Developed, designed, and executed complex research projects, reviewed progress, analyzed data, and evaluated results. • Formulated research methods and suggested options for improving quality; identified potential problems, recommended and implemented solutions. • Generated human TIL (tumor-infiltrating lymphocytes) from primary and metastatic tumors aimed at developing a cellular product for immune-based therapies for cancer patients. • Led pre-clinical studies with lung cancer animal models on combinational immune therapies as a precursor to human clinical trials. • Performed experiments in A Phase IB/II study of nivolumab in combination with ALT803 in lung cancer patients. ClinicalTrials.gov Identifier: NCT02523469. • Conducted pre-clinical studies on genetically engineering T cells. • Organized, maintained the laboratory and lab ordering, training of personnel, researching and recommending equipment, and maintaining documentation and storage of biomaterials. Show less



MUSC Hollings Cancer Center

• United States
• Hospitals and Health Care
• 1 - 100 Employee

• Research Specialist

  • 2009 - 2011

  • Evaluated and implemented the methodology of screening for distress in cancer patients. • Explored the sociodemographic, clinical, and psychosocial functioning variables in newly diagnosed breast cancer patients at the Hollings Cancer Center. • Assessed quality of life and health behaviors in survivors of head and neck cancer and their caregivers. • Presented research findings at the meetings and conferences. • Evaluated and implemented the methodology of screening for distress in cancer patients. • Explored the sociodemographic, clinical, and psychosocial functioning variables in newly diagnosed breast cancer patients at the Hollings Cancer Center. • Assessed quality of life and health behaviors in survivors of head and neck cancer and their caregivers. • Presented research findings at the meetings and conferences.



MD Anderson Cancer Center

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Student Researcher

  • 2008 - 2009

  • Conducted observational studies on assessing breast cancer patients’ behaviors after receiving a cancer diagnosis and monitored their ability to cope with stress over time. • Investigated the potential correlation between levels of stress and disease progression. • Presented research findings in a form of the presentation entitled “Stress and Cancer: Does it Affect • Treatment Outcome” at the M.D. Anderson Cancer as a Continuing Education opportunity for all of the nurses at… Show more • Conducted observational studies on assessing breast cancer patients’ behaviors after receiving a cancer diagnosis and monitored their ability to cope with stress over time. • Investigated the potential correlation between levels of stress and disease progression. • Presented research findings in a form of the presentation entitled “Stress and Cancer: Does it Affect • Treatment Outcome” at the M.D. Anderson Cancer as a Continuing Education opportunity for all of the nurses at M.D. Anderson. Show less • Conducted observational studies on assessing breast cancer patients’ behaviors after receiving a cancer diagnosis and monitored their ability to cope with stress over time. • Investigated the potential correlation between levels of stress and disease progression. • Presented research findings in a form of the presentation entitled “Stress and Cancer: Does it Affect • Treatment Outcome” at the M.D. Anderson Cancer as a Continuing Education opportunity for all of the nurses at… Show more • Conducted observational studies on assessing breast cancer patients’ behaviors after receiving a cancer diagnosis and monitored their ability to cope with stress over time. • Investigated the potential correlation between levels of stress and disease progression. • Presented research findings in a form of the presentation entitled “Stress and Cancer: Does it Affect • Treatment Outcome” at the M.D. Anderson Cancer as a Continuing Education opportunity for all of the nurses at M.D. Anderson. Show less



University of Houston

• United States
• Higher Education
• 700 & Above Employee

• Graduate Research And Teaching Assistant

  • 2008 - 2009

  • Taught an online course on Multicultural Education. • Participated in faculty and professional meetings. • Planned, directed, and evaluated activities of students. • Taught an online course on Multicultural Education. • Participated in faculty and professional meetings. • Planned, directed, and evaluated activities of students.